• Users Online: 526
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 7  |  Issue : 1  |  Page : 30-34

Acinetobacter infections: Overview and treatment dilemma


Department of Microbiology, Ayushman Hospital and Health Services, New Delhi, India

Correspondence Address:
Sana Ali
9A, Shiv Shakti Apartment, Plot-10, Sector-10, Dwarka, New Delhi - 110 075
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/cjhr.cjhr_30_19

Rights and Permissions

Introduction: Acinetobacter species are known to cause serious hospital-acquired infections (HAIs), especially in the intensive care unit (ICU). The aim of this study is to estimate the burden of such infections and also to determine their sensitivity to currently available antimicrobials. Materials and Methods: The study was conducted at a tertiary care hospital in New Delhi from June 2017 to December 2018 to estimate the number of Acinetobacter isolates from clinical samples. Organisms were identified, and their susceptibility to antimicrobials was tested using VITEK-2 automated system. Results: Of the total 701 isolates recovered from clinical samples during the study, 28 (4%) were Acinetobacter species. Among them, majority (57%) of the isolates were isolated from ICU patients. Respiratory specimen yielded maximum number of isolates (46.4%). About 71.4% of isolated strains were extremely drug resistant, 10.7% were multidrug resistant, whereas 3.5% were pandrug resistant (PDR). PDR strains were found to be resistant to even the last resort antibiotics such as tigecycline and colistin. Acinetobacter baumannii was also the most common cause for HAIs (57.1%), resulting in overall mortality of 42.8% due to HAI. Conclusion: Acinetobacter has gained great importance in health-care setting by posing serious threat to patients, which is compounded by its tendency of antibiotic resistance. HAIs are usually difficult to treat, resulting in therapeutic failure and increased mortality. It signifies the need to implement strict preventive measures in hospitals and to use higher antimicrobials or combination therapy judiciously.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed69    
    Printed2    
    Emailed0    
    PDF Downloaded13    
    Comments [Add]    

Recommend this journal